George Kyrgias, Anna Zygogianni, Evanthia Kostopoulou, Vassilios Kouloulias
Department of Radiotherapy; Department of Radiation Oncology, University Hospital of Larissa, Thessaly, Greece.
J Cancer Res Ther. 2013 Oct-Dec;9(4):564-70. doi: 10.4103/0973-1482.126448.
Any papillary growth of the breast presents both a diagnostic and a therapeutic challenge: For each one of them a diagnosis of whether they are malignant or benign in nature is required as well as appropriate staging and suitable treatment. In the international literature, we find a considerable amount of different terms being used for papillary breast growths. As a result, pathological and clinical evaluation is somewhat problematic. Encapsulated papillary carcinoma (EPC) is an interesting subgroup of breast papillary tumours. Because of its rarity, there have been only a limited number of large clinical studies that safely assess its appropriate treatment and expected outcome. However, more safe data exist in terms of prognosis - which seems to be excellent, as almost all published studies regarding these tumours have confirmed so far. We present a systematic overview of breast EPC and of the most important studies published on this topic in order to make diagnosis and treatment more straightforward for cancer clinicians. The information for this review was compiled by searching the Pubmed, Medline, Scopus, Embase, and ISI Web of Science databases for articles published from 1980 through December 2012. Electronic early-release publications were also included.
对于每一个肿物,都需要诊断其本质上是恶性还是良性,以及进行适当的分期和采取合适的治疗。在国际文献中,我们发现用于乳腺乳头状肿物的术语相当多。因此,病理和临床评估存在一定问题。包膜内乳头状癌(EPC)是乳腺乳头状肿瘤中一个有趣的亚组。由于其罕见性,仅有数量有限的大型临床研究能够安全地评估其合适的治疗方法和预期结果。然而,在预后方面存在更多可靠数据——预后似乎非常好,因为到目前为止几乎所有关于这些肿瘤的已发表研究都证实了这一点。我们对乳腺EPC以及关于该主题发表的最重要研究进行了系统综述,以便让肿瘤临床医生的诊断和治疗更加直接明了。本综述的信息是通过检索1980年至2012年12月期间发表在PubMed、Medline、Scopus、Embase和ISI科学网数据库上的文章汇编而成的。电子预印本也被纳入其中。